By Mill Chart
Last update: Dec 12, 2023
SANOFI-ADR (NASDAQ:SNY) has caught the attention of dividend investors as a stock worth considering. NASDAQ:SNY excels in profitability, solvency, and liquidity, all while providing a decent dividend. Let's delve into the details.
An integral part of ChartMill's stock analysis is the Dividend Rating, which spans from 0 to 10. This rating evaluates diverse dividend factors, including yield, historical data, growth, and sustainability. NASDAQ:SNY has received a 8 out of 10:
A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:SNY has received a 7 out of 10:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:SNY was assigned a score of 8 for profitability:
Our Best Dividend screener lists more Best Dividend stocks and is updated daily.
Our latest full fundamental report of SNY contains the most current fundamental analsysis.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
SANOFI-ADR
NASDAQ:SNY (4/23/2024, 3:30:02 PM)
After market: 47.69 0 (0%)47.69
+0.54 (+1.15%)
Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.
Auddia stock is taking off on Monday with heavy trading of AUUD stock after the company received a new AI tech patent.
Apartment Income REIT stock is rising higher on Monday as investors in AIRC shares react to a deal to take the company private.
Sanofi layoffs are coming for the company's R&D employees and it makes major changes to how it handles development going forward.
With the Fear and Greed Index at 69, it's an opportune to wager on these attractive Stocks with Moonshot Potential.
With certain sectors in the domestic market appearing overstretched, these global growth stocks may offer better opportunities.